Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2007 / Cilt: 33 - Sayı: 3

Which lithotrite Is more efficient for percutaneous management of kidney stones: Pneumatic alone or pneumatic/ultrasonic combination?

Böbrek taşlarının perkütan tedavisinde hangi litotriptör daha etkilidir: tek başına pnömotik mi veya pnömotik/ultrasonik kombinasyonu mu?

Pages
302–307
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Together with clinically insignificant (<4 mm) residual stones, overall success rate was %81.8 for Group-1 and %78 for Group-2 (p>0.05).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Although the use of ultrasonic (UL) or pneumatic lithotrites (PL) has proved to be very safe and efficient in percutaneous nephrolithotomy (PCNL), they both still have some disadvantages.
📊
Key Findings & Data:Materials and Methods: A total number of 85 patients with kidney stones who would undergo PCNL were randomized into two groups.
💡
Conclusion & Impact:Together with clinically insignificant (<4 mm) residual stones, overall success rate was %81.8 for Group-1 and %78 for Group-2 (p>0.05).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Böbrek taşı · Litotripsi · Nefrostomi

Abstract

Introduction: Although the use of ultrasonic (UL) or pneumatic lithotrites (PL) has proved to be very safe and efficient in percutaneous nephrolithotomy (PCNL), they both still have some disadvantages. In order to test the hypothesis that their combination may reduce these disadvantages, the efficiency of the combined PL/UL use and PL alone were compared in this prospective study. Materials and Methods: A total number of 85 patients with kidney stones who would undergo PCNL were randomized into two groups. In Group-1 (n=44) and Group-2 (n=41), PL alone and PL/UL combination were used for stone disintegration, respectively. Results were evaluated three months after the operation with noncontrast computerized tomography. Results. Mean stone area was 729.1±372.8 mm2 for Group-1 and 652.Ü280.7 mm2 for Group-2 (p>0.05). Of the stones, 27 (31.8%), 33 (38.8%) and 25 (29.4%) were found to be solitary, multiple and staghorn respectively. Stone-free rates in Group-1 and Group-2 were %52.3 and %70.7, respectively (p>0.05). Together with clinically insignificant (<4 mm) residual stones, overall success rate was %81.8 for Group-1 and %78 for Group-2 (p>0.05). Compared to Group-1, Group-2 had less number of clinically insignificant (<4 mm) residual stones (p=0.005). Total operation time and stone disintegration time were shorter in Group-2 (p<0.05 for both). In Group-1 and Group-2 stone clearance in one minute was found 17.4 and 26.6 mm2 respectively (p<0.001). In both group, complication rates were similar and the best results were obtained in stones of solitary in number, of pelvic in localization, of calcium-oxalate-monohydrate or uric acid in composition.Conclusion: Although stone-free, overall success and complication rates are similar, the combination PL/UL is capable of disintegrating and extracting stone material at a more rapid rate than PL alone. At the same time, using combined device also prevents leaving very small residual stones. During PCNL, combined PL/UL use should be preferred over PL use alone.

Özet

Bu çalışmada, perkütan nefrolitotomide (PCNL), pnömotik ve ultrasonik litotriptör (PL/UL) kombinasyonu ile sadece pnömotik litotriptör (PL) kullanımının etkinliği karşılaştırılmıştır. Böbrek taşı nedeniyle PCNL yapılacak olan toplam 85 hasta iki gruba randomize edildi. Grup 1 (n=44) ve Grup 2'de (n=41) taş kırılması amacıyla sırasıyla sadece PL ve PL/UL kombinasyonu kullanıldı. Sonuçlar ameliyattan üç ay sonra çekilen kontrastsız bilgisayarlı tomografi (BT) ile değerlendirildi. Grup-1'de ortalama taş alanı 729.Ü372.8 mm2, Grup-2'de 652.1±280.7 mm2 idi (p>0.05). Olguların 27 (%31.8), 33 (%38.8) ve 25'inde (%29.4) taşlar sırasıyla tek, birden çok ve geyik boynuzu (staghorn) idi. Grup l'de taşsızlık oranı %52.3, Grup 2'de %70.7 Dulundu (p>0.05). Klinik önemsiz artık taşlar ( 0.05). Grup 2'de Grup l'e kıyasla daha az sayıda klinik önemsiz artık kalmaktaydı (p=0.005). Toplam ameliyat ve taş kırma süreleri Grup 2'de daha kısaydı (her ikisi için p<0.05). Grup 1 ve Grup 2'de bir dakikadaki ortalama taş klerensi sırasıyla 17.4 ve 26.6 mm2 bulundu (p<0.001). Her iki grupta da istenmeyen yan etki oranları benzer olup, en iyi sonuçlar taşların tek, pelvis yerleşimli, kalsiyum okzalat monohidrat veya ürik asit yapısında olduğu olgularda elde edildi. Taşsızlık, toplam başarı ve istenmeyen yan etki oranları benzer olmasına karşın, PLAJL kombinasyonuyla taş kırılması ve çıkarılması sadece PL kullanımına göre daha hızlı olmaktadır. Kombine alet kullanımı aynı zamanda geride çok küçük çaplı artık taşların bırakılmasını da engellemektedir. PCNL'de kombine PL/UL kullanımı tek başına PL kullanımına tercih edilmelidir.

🔖

Cite This Article

AĞRAS, K., ÜÇGÜL, Y., ALDEMİR, M., GÜRDAL, M., KAYIGİL, Ö. (2007). Which lithotrite Is more efficient for percutaneous management of kidney stones: Pneumatic alone or pneumatic/ultrasonic combination?. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 33 - Sayı: 3, 302–307. https://ajindex.com/articles/328271

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Auge BK, Lallas CD, Pietrow PK, Zhong P, Preminger GM: In vitro comparison of standard ultrasound and pneumatic lithotrites with a new combination intracorporeal lithotripsy device. Urology, 60: 28-32,2002
  2. Kuo RL, Paterson RF, Siqueira TM Jr, Evan AP, Mc- Ateer JA, Williams JC Jr, Lingeman JE: In vitro assessment of lithoclast ultra intracorporeal lithotripter. J Endourol, 18: 153-6,2004
  3. Kim SC, Matlaga BR, Tinmouth WW, Kuo RL, Evan AP, McAteer JA, Williams JC Jr, Lingeman JE: In vitro assessment of a novel dual probe ultrasonic intracorporeal lithotriptor. J Urol, 177: 1363-5, 2007
  4. Liatsikos EN, Dinlene CZ, Fogarty JD, Kapoor R, Bernardo NO, Smith AD: Efficiency and efficacy of different intracorporeal ultrasonic lithotripsy units on a synthetic stone model. J Endourol, 15: 925-928, 2001
  5. Haupt G, Haupt A: In vitro comparison of 4 ultrasound lithotripsy devices. J Urol, 70: 1731-1733,2003
  6. Olbert P, Weber J, Hegele A, Varga Z, Heidenreich A, Hofmann R: Combining Lithoclast and ultrasound power in one device for percutaneous nephrolithotomy: In vitro results of a novel and highly effective technology. Urology, 61: 55-9, 2003
  7. Rane A, Konunu SS, Kandaswamy SV, Rao P, Aron M, Kumar R, Gupta N: Initial clinical evaluation of a new pneumatic intracorporeal lithotripter. BJU Int, electronik baskı Haziran 2007
  8. Mariani AJ: Combined electrohydraulic and holmium: yag laser ureteroscopic nephrolithotripsy for 20 to 40 mm renal calculi. J Urol, 172: 170-174, 2004
  9. Hofmann R, Olbert P, Weber J, Wille S, Varga Z: Clinical experience with a new ultrasonic and LithoClast combination for percutaneous Htholapaxy. BJU Int, 90: 16-19,2002
  10. Cuellar DC, Averch TD: Holmium laser percutaneous nephrolithotomy using a unique suction device. J Endourol 18: 780-782, 2004
  11. Jou YC, Shen JH, Cheng MC, Lin CT, Chen PC: Percutaneous nephrolithotomy with holmium: Yttrium-aluminum- garnet laser and fiber guider—report of 349 cases. Urology, 65: 454-458, 2005
  12. Denstedt JD: Use of Swiss Lithoclast for percutaneous nephrolithotripsy. J Endourol, 7: 477-480, 1993
  13. Pietrow PK, Auge BK, Zhong P, Preminger GM: Clinical efficacy of a combination pneumatic and ultrasonic lithotrite. J Urol, 169: 1247-1249, 2003
  14. Grocela JA and Dretler SP: Intracorporeal lithotripsy. Urol Clin North Am, 24: 13-23, 1997
  15. Teichman JM, Vassar GJ, Glickman RD: Ho YAG lithotripsy efficiency varies with stone composition. Urology, 52: 392-397, 1998
  16. Teh CL, Zhong